|
Ferroptosis in I/R injury | Experiment | Number () | Model/study population | Intervention | Target | Reference |
|
Myocardial I/R injury | In vitro | Not applicable | Mouse embryonic fibroblasts | Not available | Glutaminolysis | [70] |
In vitro | Not applicable | H9c2 cells | C3G | Ferroptosis-related protein, NCOA4, RSL3 | [72] |
In vitro | Not applicable | Adult rat cardiomyocytes | Ferrostatin-1 | OxPCs | [76] |
In vitro | Not applicable | H9c2 cells | Baicalin | ACSL4 | [82] |
In vitro | Not applicable | Human cardiomyocytes | ELAVL1 knockout | Not available | [84] |
In vivo | Not applicable | I/R-treated Sprague–Dawley rats | Not available | Upregulation of USP7 | [74] |
In vivo | Not applicable | Murine models of doxorubicin- and I/R-induced cardiomyopathy | Ferrostatin-1 and iron chelator | Not available | [77] |
In vivo | Not applicable | Sprague–Dawley rats | C3G | Ferroptosis-related protein, NCOA4, RSL3 | [72] |
In vivo | Not applicable | Myocardial I/R rat model | Baicalin | ACSL4 | [82] |
In vivo | Not applicable | Sprague–Dawley rats | USP22 | Not available | [83] |
Clinical finding | 60 | Patients with ST-elevation-myocardial infarct | DFO | Not available | [78] |
Clinical finding | 45 | Patients undergoing coronary artery bypass grafting | DFO | Not available | [79] |
|
Cerebral I/R injury | In vitro | Not applicable | Primary cortical neurons and hippocampal HT22 cells | Selenium | GPX4 | [92] |
In vivo | Not applicable | C57BL/6 mice | Selenium | GPX4 | [92] |
In vivo | Not applicable | Sprague–Dawley rats | Liproxstatin-1, Ferrostatin-1 | Not available | [95] |
In vivo | Not applicable | Brain I/R mice model | Carthamin yellow | Not available | [96] |
In vivo | Not applicable | Mice models of cerebral I/R | MiR-214 | PVT1, TFR1, TP53 | [97] |
In vivo | Not applicable | Ischemic stroke model gerbils | Carvacrol | GPX4 | [98] |
In vivo | Not applicable | Ischemic stroke model gerbils | Galangin | SLC7A11, GPX4 | [100] |
In vivo | Not applicable | Mice models | Knockdown of ACSL4 | Not available | [102] |
|
Ischemic renal injury | In vivo | Not applicable | C57BL/6 mice | Ferrostatin 1 or 16–86 | Not available | [106] |
In vivo | Not applicable | I/R-induced renal injury rat models | Not available | GPX4, SLC7A11 | [107] |
In vivo | Not applicable | Mice models | PANX1 deletion | Not available | [108] |
In vivo | Not applicable | Mif-/- mice | MIF | GSH | [109] |
In vivo | Not applicable | Renal I/R injury mice model | Pachymic acid | GPX4, SLC7A11, and HO-1 | [110] |
In vivo | Not applicable | Renal I/R mice model | XJB-5-131 | Not available | [111] |
In vivo | Not applicable | Renal I/R mice model | Irisin | GPX4 | [112] |
|
Hepatic I/R injury | In vivo | Not applicable | Gpx4-/- mice | Knockout of GPX4 | Not available | [6] |
In vivo | Not applicable | Murine hepatic I/R injury model | Iron overload | Not available | [116] |
|
Intestinal I/R injury | In vitro | Not applicable | Caco-2 cells | Rosiglitazone, si-special protein 1 | ACSL4 | [117] |
In vitro | Not applicable | Ileum organoid H/R model | Capsiate | GPX4, TRPV1 | [119] |
In vivo | Not applicable | Murine model of intestinal I/R | Rosiglitazone, si-special protein 1 | ACSL4 | [117] |
In vivo | Not applicable | Mouse intestinal I/R model | Capsiate | GPX4, TRPV1 | [119] |
|
Acute lung injury induced by intestinal I/R | In vivo | Not applicable | C57BL/6J mice and Nrf2-/- mice | Nrf2 | SLC7A11, HO-1 | [122] |
In vivo | Not applicable | Nrf2-/- mice with acute lung injury induced by intestinal I/R | Inhibitor of apoptosis-stimulating protein of P53 | Nrf2 | [123] |
|